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The latest threat of multidrug-resistant Gram-negative bacteria corresponds to the emergence of carbapenemase
New Delhi metallo-β-lactamase (NDM) and Klebsiella pneumoniae carbapenemase (KPC) producers. Rapid molecular
detection is essential to limit their spread. In this study, a duplex real-time polymerase chain reaction (PCR) that was
specific for the detection of blaNDM and blaKPC with the same limit of detection of ten plasmid copies was
developed. The assay was linear over eight log dilutions for blaNDM (R
2 = 0.971; slope, -3.273) and blaKPC (R
2 = 0.992;
slope, -2.997) with efficiencies of 102% and 115%, respectively. The assay was validated with 157 clinical isolates and
showed 100% concordance with conventional PCR. The excellent performance of the duplex PCR assay makes it a
powerful tool for surveillance of the carbapenemases NDM and KPC.
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Carbapenems such as imipenem and meropenem are
considered the drugs of choice for treating severe in-
fections caused by Enterobacteriaceae-producing extended-
spectrumβ-lactamases (ESBLs). Increasing resistance to
carbapenems is now frequently observed in many hospital-
acquired and community-acquired Enterobacteriaceae
rods [1,2]. The association of carbapenem-resistant
Enterobacteriaceae (CRE) with therapeutic failure and the
resulting high mortality rates is of serious concern. Although
several mechanisms of carbapenem resistance have been
reported, the production of carbapenemases is the most
common mechanism [2]. A large variety of clinically
relevant carbapenemases, including Guiana extended-
spectrum β-lactamases (GES), Klebsiella pneumoniae
carbapenemase (KPC), Verona integron-encoded metallo-β-
lactamase (VIM), imipenem-hydrolyzing β-lactamases
(IMP), Sao Paulo metallo-β-lactamase (SPM), German
imipenemase (GIM), Seoul imipenemase (SIM), and
oxacillinase-48 (OXA-48) type, and rapidly emerging New
Delhi metallo-β-lactamaseo-1 (NDM-1) have been reported* Correspondence: yongyuruigroup@sina.com
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stated.[1,3]. In particular, since KPC producers were first reported
in the United States in 1996 and NDM producers were first
reported in India in 2008, both have rapidly emerged world-
wide as important causes of extreme drug resistance [3-5].
The increasingly common class A enzyme KPCs and the
latest metallo-β-lactamase NDMs are able to hydrolyze
nearly all β-lactams; moreover, almost all of their producers
are broadly resistant to other drug classes in addition to β-
lactams due to a diversity of other resistance mechanisms
(e.g. to aminoglycosides and fluoroquinolones), leaving phy-
sicians with limited antibiotic choices for treating infected
patients [1,6,7]. KPC enzymes have been reported in nu-
merous Enterobacteriaceae genera and even in non-
fermenting bacteria, although KPCs are mostly identified
from K. pneumoniae. In addition, KPC-producing isolates
have disseminated worldwide, including several countries
across Asia, America and Europe. The blaKPC genes are al-
most present on transferable plasmids and are flanked by
transposable elements [8-10], which allows for potential
dissemination among different species. Similarly, the
blaNDM genes are primarily located on plasmids belonging
to several incompatibility groups, and the diversity of
genetic features associated with the blaNDM genes may
explain its current high worldwide spread rate [11,12].
NDM enzymes have been recognized among differentLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Zheng et al. Annals of Clinical Microbiology and Antimicrobials 2013, 12:30 Page 2 of 5
http://www.ann-clinmicrob.com/content/12/1/30Enterobacteriaceae species as well as in non-fermenters
and Vibrionaceae and have been reported worldwide in
Asia, Europe, North America, Australia and the Middle
East since 2008. To date, thirteen blaKPC gene variants
(classified in sequential numeric order from blaKPC-1/2 to
blaKPC-15) have been described and six minor NDM vari-
ants (blaNDM-2 to blaNDM-8) have been identified (http://
www.lahey.org/studies/).
The carbapenemases KPC and NDM have already
become a worldwide public health issue due to their
widespread distribution, broad range of activity
against β-lactams and aggressive hazards to human
beings. As a result, the sensitive and rapid detection
of the blaNDM and blaKPC genes is essential for imple-
mentation of the infection control procedures that are
required to limit their spread and to help clinicians
guide individual patient management. In this study,
we developed a duplex TaqMan probe-based real-time
polymerase chain reaction (PCR) assay for the prompt
and simultaneous detection of the blaNDM and blaKPC
genes in bacteria in a single tube.Materials and methods
Primer and probe design
The details of the reference genes used in this assay are
provided at http://www.lahey.org/studies/. The reference
gene sequences for the NDM and KPC enzyme families
were assembled from GenBank (http://www.ncbi.nlm.nih.
gov/GenBank) as NDM accession numbers FN396876,
JF703135, JQ734687, JQ348841, JN104597, JN967644,
JX262694 and AB744718 representing alleles 1–8 and as
KPC accession numbers AY034847, AF395881, AY700571,
EU400222, EU555534, EU729727, FJ234412, FJ624872,
GQ140348, HM066995, HQ641421, HQ342890, JX524191
and KC433553 representing alleles 2–15. Based on the
comprehensive analyses and alignments of both gene fam-
ilies, primers and probes for the duplex real-time PCR assay
were specifically designed to amplify all alleles of each gene
family described above using Beacon Designer software
(Premier Biosoft, Palo Alto, CA, USA) (Table 1). All of the
primers and probes were synthesized by TaKaRa Bio, Inc.
(Dalian, China).Table 1 Primers and probes used in duplex real-time PCR






KPC-probe FAM –CCACTGTGCAGCTCRecombinant plasmids pNDM-1 and pKPC-2
The recombinant plasmids pNDM-1 and pKPC-2, com-
posed of a pMD18-T backbone carrying a 4-kb insert ex-
pressing NDM-1 and KPC-2 carbapenemase, respectively,
were used to optimize the quantitative PCR (qPCR).Bacterial strains and antibiotic susceptibility testing
A total of 157 Enterobacteriaceae isolates were collected
at Nanfang Hospital from June 2010 to September 2012,
including 17 resistant to imipenem or meropenem iso-
lates and 140 randomly collected isolates with suscep-
tible to imipenem and meropenem. All the isolates had
previously been tested for blaKPC, blaIMP, blaVIM, blaNDM
and blaOXA-48 using conventional PCR and sequencing
[13-15]. Of them, 17 carbapenem–resistant isolates
harbored the carbapenemase genes blaKPC, blaIMP or
blaNDM, including nine blaKPC-2-positive K. pneumoniae,
one K. pneumoniae carrying blaKPC-2 and blaIMP-4,
three blaNDM-1-positive K. pneumoniae, one Klebsiella
oxytoca and one each blaNDM-1-positive Enterobacter
hormaechei, Enterobacter cloacae and Enterobacter
aerogenes. The other 140 Enterobacteriaceae isolates
were negative for the five tested carbapenemase genes.
In addition, ten NDM/KPC non-producers, including
Escherichia coli ATCC 25922, K. pneumoniae ATCC
700603, Staphylococcus aureus ATCC 25923, Pseudo-
monas aeruginosa ATCC 27853 and six known clinical
strains without any carbapenemase gene(two Entero-
coccus spp., two Streptococcus spp. and two Staphylococ-
cus spp.), were used to evaluate the specificity of the
duplex qPCR assay.
All bacterial identification and susceptibility testing was
performed using a BD Phoenix 100 Automated Microbiol-
ogy System (Benton, Dickinson and Co., Franklin Lakes,
NJ, USA). The results were interpreted according to the
Clinical and Laboratory Standards Institute guidelines. The
isolates were stored at −80°C in nutrient broth containing
30% (v/v) glycerol.DNA extraction
Fresh, well-isolated colonies were used for total bacterial
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the manufacturer’s protocol. Extracted DNA was eluted
from the columns in 100 μL of elution buffer and stored at
−20°C.Duplex real-time PCR reaction
The TaqMan probe-based real-time PCR assay was
performed on an ABI Prism 7500 Fast apparatus (Applied
Biosystems, Foster City, CA, USA) using the Premix Ex
Taq™ (Probe qPCR) kit (TaKaRa Bio, Inc.) as recommended
by the manufacturer. The 20-μL qPCR mixture contained 2
μL of DNA extract solution, 10 μL of Premix Ex Taq Probe
qPCR (2×), 0.4 μL of ROX Reference Dye II (50×), 0.2 μM
of each primer and 0.1 μM of each TaqMan probe, and
sterile water to a final volume of 20 μL. The optimal cycling
conditions were 20 s at 95°C and 40 cycles each of 3 s at
95°C and 30 s at 60°C. Each run contained a positive con-
trol (mixture of recombinant plasmids pNDM-1 and
pKPC-2) for blaNDM and blaKPC amplification and at least
one water blank as a negative control.Standard curve and sensitivity test on recombinant
plasmids
To determine the efficiency of the duplex real-time PCR
assay, Ct values obtained from a series of template DNA di-
lutions were graphed on the y axis versus the log of the dilu-
tion on the x axis. The slope of this line was used to
determine efficiency (E) according to this equation: E = 10
(−1/slope). Assay sensitivity and reproducibility were estimatedFigure 1 Duplex real-time PCR 10-fold dilution series. E: Efficiency; R2: c
log of the starting quantity of template for each dilution) and amplificationby serial ten-fold dilution experiments using the mixture of
recombinant plasmids pNDM-1 and pKPC-2.
Results
The assay was initially validated using the recombinant
plasmids pNDM-1 and pKPC-2 carrying the blaNDM-1
and blaKPC-2 genes. Clearly defined amplification curves
were observed for the two positive recombinant plas-
mids in their predicted fluorescence channels.
Primer and probe specificities were evaluated at the
National Center for Biotechnology Information database
(http://www.ncbi.nlm.nih.gov). No matches to the pri-
mer or probe sequences of blaNDM and blaKPC were
found other than those for corresponding blaNDM and
blaKPC genes. The analytical specificity was also applied
on clinically representative bacteria with no known anti-
biotic resistance gene, including E. coli ATCC 25922, K.
pneumoniae ATCC 700603, S. aureus ATCC 25923, P.
aeruginosa ATCC 27853, Enterococcus spp. (two iso-
lates), Staphylococcus spp. (two isolates) and Streptococ-
cus spp. (two isolates). The recombinant plasmids
pNDM-1 and pKPC-2 were used as positive controls.
No amplification of blaNDM or blaKPC was observed with
DNA extracted from any of the ten organisms on our
specificity test panel. Thus, the specificity of our duplex
PCR is considered satisfactory.
Assay linearity and limit of detection were determined by
performing serial ten-fold dilutions of a mixture of the re-
combinant plasmids pNDM-1 and pKPC-2 from 10 to 108
copies/μL (Figure 1). The assay correlated well with blaNDMoefficient of determination. Standard curves (Ct plotted against the
curves of the dilution series for (A, B) blaNDM and (C, D) blaKPC.
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2 = 0.992) over the entire copy
range with an efficiency of 102% and 115%, respectively.
The limit of detection for both targets was 10 copies per
20-μL reaction volume.
We have also shown that the assay was highly stable and
precise as evidenced by the performance of the recombin-
ant plasmid pNDM-1 (105 copies of blaNDM-1-carrying
plasmid) and pKPC-2 (105 copies of blaKPC-2-carrying plas-
mid), which were stable over five consecutive runs for both
blaNDM (mean Ct, 22.8; standard deviation, 0.4; coefficient
of variation, 1.8%) and blaKPC (mean Ct, 19.3; standard de-
viation, 0.1; coefficient of variation, 0.5%).
Finally, when tested against the 157 previously charac-
terized carbapenem-resistant Enterobacteriaceae isolates,
including seven with NDM-1 metallo-carbapenemases,
ten with KPC-2 serine carbapenemases and 140 strains
without blaNDM and blaKPC carbapenemases, the duplex
PCR assay showed 100% concordance with conventional
PCR previously identified. In our opinion, the 100% sen-
sitivity and specificity of the duplex PCR validated
against clinical isolates of carbapenem-resistant Gram-
negative bacilli with well-defined carbapenemase genes
make it a useful tool for the screening and surveillance
of isolates carrying the carbapenemase genes blaNDM
and blaKPC.
Discussion
The co-occurrence of blaNDM-1 and blaKPC-2 in a clinical
isolate of K. pneumoniae from India was recently reported
[7], suggesting that the growing emergence of these power-
ful resistance mechanisms should be given great attention.
Considering the difficulty in preventing their emergence
due to the potential for rapid horizontal and vertical trans-
mission determined by genetics and treating patients
infected with blaNDM and blaKPC harboring bacterial patho-
gens, active surveillance and early detection are mandatory
for preventing their further spread.
Molecular assays have been reported to identify
carbapenemase genes in Gram-negative bacteria. Several
real-time PCR assays targeting NDM-1 or KPC have
been described [16-20], but each targets only one kind
of carbapenemase gene. Assays that target more than
one class of carbapenemase (A, B, D) have been devel-
oped [15,21], but each of those uses conventional PCR
requiring post-amplification analysis. Real-time PCR re-
quiring less time and labor for the simultaneous detec-
tion of multiple carbapenemase genes including NDM
and KPC is rare. Monteiro et al. described a multiplex
real-time PCR for the rapid detection of KPC, GES,
NDM, IMP, VIM and OXA-48 carbapenemase genes
using melt curve analysis [22], however, no details of the
assay design for the detection of all blaNDM types other
than blaNDM-1 were provided. The presently described
duplex PCR assay is capable of simultaneously detectingall of the minor blaNDM-1 variants since the nucleotide
changes between the variants are located outside the
primer- and probe-binding sequences. Likewise, in the
case of blaKPC, the assay described here is expected to
amplify all known blaKPC types. Although our duplex
PCR assay was validated with Gram-negative bacteria, it
could amplify the expected product from all blaKPC- and
blaNDM-carrying isolates, including Gram-positive bac-
teria. Recently, Cunningham SA et al. described a FRET
hybridization probe-based real-time PCR assay that tar-
gets blaKPC and blaNDM in a single assay [23]. Although
the assay performed equivalently to our assay, the FRET
hybridization probe is more expensive than ours
TaqMan probe. Additionally, the FRET hybridization
probe-based real-time PCR assay needs LightCycler in-
strument(Roche Applied Science, Indianapolis, IN) to
match it, which limited its wide application; the classic
TaqMan probe in our assay is suitable for any real-time
PCR detection system, which has wider applicability.
In conclusion, we successfully established a novel duplex
real-time PCR assay for the prompt and simultaneous
screening of the blaNDM and blaKPC genes in a single reac-
tion that had good sensitivity and specificity and excellent
agreement with conventional PCR and sequencing. The ex-
cellent performance of duplex PCR makes it an important
tool for guiding the appropriate choice of antimicrobial
therapy and helping limit spread of the resistance genes
through aggressive infection control measures. Its use
would be especially suitable for national epidemiological
purposes in an outbreak situation thanks to its comprehen-
sive ability to detect all known blaNDM and blaKPC variants.
Nucleotide sequence accession number
The GenBank accession numbers are JN711113, JN711114,
KC404861, KC539432, KC539429, KC539430 and
KC539431, for the blaNDM-1 gene from strains 920856,
903966, 917144, 23142, 24192, 27378 and 208741, respect-
ively, and JF431928, JF894295-JF894300, JQ040039, and
JQ040040 for the blaKPC-2 gene from nine KPC-2-
producing K. pneumonia, respectively. The blaKPC-2 gene of
One K. pneumonia carrying both blaKPC-2 and blaIMP-4
genes did not been lodged in GenBank.
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